NC Retina Associates

Clinical research site in Cary, North Carolina · NC Retina Associates, 106 Ridgeview Dr ste 100, Cary, NC 27511 · (919) 782-8038 · Website

As of July 2026, 5 paid clinical trials are recruiting at NC Retina Associates in Cary, North Carolina. Active studies at this site cover conditions such as Age - Related Macular Degeneration (AMD), Geographic Atrophy (GA) and Neovascular Age-Related Macular Degeneration (nAMD). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at NC Retina Associates (5)

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for Age-related Macular Degeneration (AMD)

140 locations incl. Chandler

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 50 - 85

Code: NCT06541704·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

for Macular Edema Secondary to Inflammation

53 locations incl. Phoenix

Sponsor: Kodiak Sciences Inc

Sex: All·Age: 18+

Code: NCT06996080·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

for Geographic Atrophy (GA)

49 locations incl. Gilbert

Sponsor: ONL Therapeutics

Sex: All·Age: 55+

Code: NCT06659445·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

for Macular Edema Secondary to Inflammation

53 locations incl. Phoenix

Sponsor: Kodiak Sciences Inc

Sex: All·Age: 18+

Code: NCT06990399·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

for Neovascular Age-Related Macular Degeneration (nAMD)

54 locations incl. Scottsdale

Sponsor: 4D Molecular Therapeutics

Sex: All·Age: 50+

Code: NCT07064759·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

More research sites in Cary

Duke Cancer Center Cary (14 trials)
True You Weight Loss (4 trials)
UNC Health Cancer Care Cary (3 trials)
Accellacare - Cary (2 trials)
North Carolina Retina Associates (2 trials)
North Carolina Retina Associates (Cary) (2 trials)
Vascular Solutions of North Carolina (2 trials)
Waverly Hematology Oncology (2 trials)
Magnolia Clinical Research, LLC (2 trials)
WakeMed Cancer Care - Waverly Hematology & Medical Oncology (2 trials)

Explore more

Paid clinical trials in Cary, NC · North Carolina clinical trials